The unrestricted use of paclitaxel-versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent …

ATL Ong, PW Serruys, J Aoki, A Hoye… - Journal of the American …, 2005 - jacc.org
Objectives: We investigated the efficacy of paclitaxel-eluting stents (PES) compared to
sirolimus-eluting stents (SES) when used without restriction in unselected patients …
被引用次数：312 相关文章

The unrestricted use of paclitaxel-versus sirolimus-eluting stents for coronary artery disease in an unselected population: One-year results of the Taxus-Stent …

A Ong, P Serruys, J Aoki, A Hoye… - Journal of the …, 2005 - repub.eur.nl
OBJECTIVES: We investigated the efficacy of paclitaxel-eluting stents (PES) compared to
sirolimus-eluting stents (SES) when used without restriction in unselected patients …
[HTML] sciencedirect.com

[HTML][HTML] The unrestricted use of paclitaxel-versus sirolimus-eluting stents for coronary artery disease in an unselected population: One-year results of the Taxus-Stent …

ATL Ong, PW Serruys, J Aoki, A Hoye… - Journal of the American …, 2005 - Elsevier
OBJECTIVES: We investigated the efficacy of paclitaxel-eluting stents (PES) compared to
sirolimus-eluting stents (SES) when used without restriction in unselected patients …

[引用][C] The unrestricted use of paclitaxel-versus sirolimus-eluting stents for coronary artery disease in an unselected population: One-year results of the Taxus-Stent …

ONG AT - J Am Coll Cardiol, 2005 - cir.nii.ac.jp
The unrestricted use of paclitaxel-versus sirolimus-eluting stents for coronary artery disease
in an unselected population : One-year results of the Taxus-Stent Evaluated at Rotterdam …

The unrestricted use of paclitaxel-versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent …

ATL Ong, PW Serruys, J Aoki… - Journal of the …, 2005 - pubmed.ncbi.nlm.nih.gov
Objectives We investigated the efficacy of paclitaxel-eluting stents (PES) compared to
sirolimus-eluting stents (SES) when used without restriction in unselected patients …

[引用][C] The unrestricted use of paclitaxel-versus sirolimus-eluting stents for coronary artery disease in an unselected population: One-year results of the taxus-stent …

ATL ONG, PW SERRUYS… - Journal of the …, 2005 - pascal-francis.inist.fr
Author ONG, Andrew T. L 1; SERRUYS, Patrick W 1; DE JAEGERE, Peter P. T 1;
MCFADDEN, Eugene P 1; SIANOS, Georgios 1; VAN DER GIESSEN, Willem J 1; DE …

The unrestricted use of paclitaxel-versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent …

AT Ong, PW Serruys, J Aoki, A Hoye… - Journal of the …, 2005 - europepmc.org
Objectives We investigated the efficacy of paclitaxel-eluting stents (PES) compared to
sirolimus-eluting stents (SES) when used without restriction in unselected patients …

The unrestricted use of paclitaxel-versus sirolimus-eluting stents for coronary artery disease in an unselected population

ATL Ong, PW Serruys, J Aoki, A Hoye… - Journal of the American …, 2005 - infona.pl
We investigated the efficacy of paclitaxel-eluting stents (PES) compared to sirolimus-eluting
stents (SES) when used without restriction in unselected patients. Both SES and PES have …

The Unrestricted Use of Paclitaxel-Versus Sirolimus-Eluting Stents for Coronary Artery Disease in an Unselected Population: One-Year Results of the Taxus-Stent …

ATL Ong, PW Serruys, J Aokiet - ACC Current Journal Review, 2005 - infona.pl
The Unrestricted Use of Paclitaxel- Versus Sirolimus-Eluting Stents for Coronary Artery
Disease in an Unselected Population: One-Year Results of the Taxus-Stent Evaluated At …

[引用][C] The unrestricted use of paclitaxel-versus sirolimus-eluting stents for coronary artery disease in an unselected population: One-year results of the taxus-stent …

ATL ONG, PW SERRUYS, J AOKI, A HOYE… - Journal of the American …, 2005 - Elsevier